Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

AGM Statement

12 Sep 2006 07:01

Marchpole Holdings PLC12 September 2006 Marchpole Holdings plc ("Marchpole" or "the Company") Annual General Meeting Statement At Marchpole Holding's Annual General Meeting to be held this morning, thenon-executive Chairman of Marchpole Holdings plc, Christopher Phillips, willgive the following statement and update on current trading. "At the time of the announcement on 28 June 2006 of our results for the yearended 31 March 2006 I was pleased to report continued improvement in thebusiness with increased turnover and operating profit and a strong forward orderbook. In line with our strategy, the Company continues to evolve from asingle-brand, single country business to a diversified, international businesswith a portfolio of brands. We have significantly extended our global reach andnow operate in the UK, Europe, Asia, the US and the Middle East. The current financial year has started well, with deliveries and orders forAutumn/Winter collections at record levels and our Spring/Summer 2007collections for all our brands having been well received and forward order booksbuilding in line with expectations. We are pleased to report that the integration of Moda America, the US licenseefor Emanuel Ungaro which was acquired in March 2006, has been successful andimmediately earnings enhancing. It has provided the Company with an opportunityto expand significantly the business into the USA. Importantly, the Boardbelieves business from Moda will offset the termination of the YSL licence inDecember 2006. Furthermore, not only does it strengthen our relationship withEmanuel Ungaro but it also provides us with the opportunity to re-launch ourwholly-owned brand, Jean Charles de Castelbajac ("JCC"), into America witheffect from Autumn/Winter 2006. Our JCC brand continues to build on progress with expanded reach and increase inlicensing income which has more than doubled since acquisition. In May 2006, wesigned an agreement with global childrenswear retailer OKAIDI Group to develop arange of childrenswear under the JCC brand. This licence provides us with afoothold in the childrenswear market, which we believe is an area that offersconsiderable opportunity for growth. In June we signed a contract with Galleries Lafayette to open a JCC'shop-in-shop' in the landmark Galleries Lafayette department store on BoulevardHausman in Paris. Clothes and accessories from the JCC range have been sold inthe iconic store since July 2006 and current trading is encouraging. In additionan agreement with leading European eyewear retailer Codir SA resulted in thelaunch of a Castelbajac eyewear range. During the last year we also extended our design agreement and increased licenceincome with our Japanese partner, Itochu, for a further six years until 2011which enables us to maximise the potential for the JCC brand in the lucrativeJapanese market. Earlier this month we opened our Japanese flagship store inKobe, to be followed by a Tokyo JCC store in the near future. Good progress has also been made with the Emanuel Ungaro and Ungaro Hommelicences. The growth potential of the Ungaro brand was confirmed with our recentdistribution agreement with Dubai based BTC Group International, for the EmanuelUngaro brand to be sold in the United Arab Emirates. The agreement was a majorbreakthrough into the fast growing Gulf marketplace and further extends theinternational reach of the brand. We continue to work closely with the House ofUngaro and we are confident that revenue from the Ungaro brand will replace thatfrom Yves Saint Laurent in the medium term. Most recently, Marchpole acquired Homebody, the luxury clothing company whichdesigns, manufactures and distributes ladieswear, maternity wear and menswear.It is currently stocked in Selfridges and Harrods as well as top boutiquesacross the UK and by Neiman Marcus in the USA. We intend to build the brandfurther throughout Europe and the US, using our global network of distributionoutlets to accelerate growth. We therefore look forward to the future with confidence. Orders and deliveriesfor Autumn / Winter 2006 remain very strong and our forward order book isbuilding in line with expectations. Marchpole is well placed to capitalise onfuture licensing opportunities and suitable earnings-enhancing acquisitions." In addition to the Chairman's statement, included within the special businessfor approval at the AGM are proposals for a share consolidation and buy-back.The share consolidation is on the basis that every five existing ordinary sharesof 1p each be consolidated and redesignated as one new ordinary share of 5peach. Application will be made to the UK Listing Authority for the new ordinaryshares to be admitted to the Official List and to be admitted to trading on theLondon Stock Exchange and it is expected that dealings in the new ordinaryshares will commence on 18 September 2006. For further information, please contact : Emma Kent / Alexandra WaltonBell Pottinger Corporate & Financial 020 7861 3232 John Harrison, Finance DirectorMarchpole 020 7908 7777 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th May 20177:00 amRNSInitiation of BPS-804 Phase 2b study
28th Apr 20173:37 pmRNSHolding(s) in Company
28th Apr 201712:53 pmRNSHolding(s) in Company
28th Apr 201710:05 amRNSHolding(s) in Company
26th Apr 20177:00 amRNSConversion of loan note and issue of equity
24th Apr 20176:07 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSGrant of Options and Awards
3rd Apr 20177:00 amRNSResults of Placing
31st Mar 20175:54 pmRNSResults of Placing
29th Mar 201712:30 pmRNSProposed Placing
15th Mar 20177:00 amRNSPosting of Annual Report and Notice of AGM
7th Mar 20177:00 amRNSPositive recommendation for BGS-649 Phase 2b trial
27th Feb 20177:00 amRNSPreliminary Results
20th Feb 20177:00 amRNSEMA Adaptive Pathways programme accepts BPS-804
23rd Jan 20177:05 amRNSPresentation at Shares Spotlight Evening
23rd Jan 20177:00 amRNSThree abstracts accepted for ATS Meeting
12th Jan 20177:01 amRNSDirectorate update
5th Jan 201712:00 pmRNSMereo BioPharma to Present at Biotech Showcase
12th Dec 20167:00 amRNSBusiness Update
7th Nov 20167:10 amRNSAppointment of Chief Financial Officer
3rd Nov 20167:00 amRNSPositive Phase 1 interaction study with BCT-197
5th Oct 20167:00 amRNSDirectorate Change
16th Sep 20167:00 amRNSHalf-year Report
9th Aug 20164:04 pmRNSNotice of Results
18th Jul 20161:25 pmRNSResult of AGM
30th Jun 20167:00 amRNSBPS-804 granted EU orphan drug status
24th Jun 201612:47 pmRNSNotice of AGM
9th Jun 20161:17 pmRNSDirector/PDMR Shareholding
9th Jun 20168:01 amRNSFirst Day of Dealings on AIM
10th Nov 20086:21 pmRNSFurther re financial position
4th Nov 20083:01 pmRNSStatement re suspension
4th Nov 20083:00 pmRNSSuspension
23rd Oct 20084:35 pmRNSHolding(s) in Company
23rd Oct 20082:25 pmRNSAGM Statement
2nd Oct 20083:14 pmRNSHolding(s) in Company
23rd Sep 200810:02 amRNSNotice of AGM
1st Sep 200810:06 amRNSHolding(s) in Company
29th Aug 20083:20 pmRNSResult of GM and Interim Mana
26th Aug 200810:13 amRNSHolding(s) in Company
19th Aug 20082:22 pmRNSHolding(s) in Company
14th Aug 20084:23 pmRNSHolding(s) in Company
13th Aug 200811:00 amRNSDirectorate Change
8th Aug 200811:14 amRNSHolding(s) in Company
8th Aug 200811:03 amRNSHolding(s) in Company
7th Aug 20084:46 pmRNSHolding(s) in Company
6th Aug 20084:41 pmRNSSecond Price Monitoring Extn
6th Aug 20084:36 pmRNSPrice Monitoring Extension
6th Aug 20083:17 pmRNSDirector/PDMR Shareholding
6th Aug 20087:08 amRNSFundraising and New Board App
6th Aug 20087:05 amRNSNew Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.